Literature DB >> 20843489

Lifestyle changes and reduction of colon cancer incidence in Europe: A scenario study of physical activity promotion and weight reduction.

E de Vries1, I Soerjomataram, V E P P Lemmens, J W W Coebergh, J J Barendregt, A Oenema, H Møller, H Brenner, Andrew G Renehan.   

Abstract

BACKGROUND: Across Europe, there are over 300,000 new cases of colorectal cancer annually. Major risk factors include excess body weight (usually expressed by a high body mass index, BMI) and physical inactivity (PA). In this study we modelled the potential long-term effects on colon cancer incidence of changes in prevalence of excess body weight and physical inactivity in seven European countries across Europe with adequate data.
METHODS: We addressed the impact of interventions aimed at preventing weight gain and increasing physical activity on colon cancer incidence using the Prevent model as refined in the FP-6 Eurocadet project. Relative risk (RR) estimates were derived from meta-analyses; sex- and country-specific prevalences of BMI and PA were determined from survey data. Models were made for Czech Republic, Denmark, France, Latvia, the Netherlands, Spain and the United Kingdom.
RESULTS: In a hypothetical scenario in which a whole population had obtained an ideal weight distribution in the year 2009, up to 11 new cases per 100,000 person-years would be avoided by 2040. The population attributable fractions (PAF) for excess weight were much higher for males (between 13.5% and 18.2%) than for females (2.3-4.6%). In contrast, using the optimum scenario where everybody in Europe would adhere to the recommended guideline of at least 30 min of moderate PA 5d per week, the PAFs for PA in various countries were substantially greater in women (4.4-21.2%) than in men (3.2-11.6%). Sensitivity analyses were performed assuming underreporting of BMI by using self-reports (difference of 5 and 0.8 percent-points in males and females, respectively), using different risk estimates (between 5.8 and 11.5 percent-points difference for BMI for men and women, respectively, and up to 11.6 percent-points difference for PA for women).
INTERPRETATION: Changes in lifestyle can indeed result in large health benefits, including for colon cancer. Two interesting patterns emerged: for colon cancer, achieving optimum BMI levels in the population appears to offer the greatest health benefits in population attributable fractions in males, while increased physical activity might offer the greatest fraction of avoidable cancers in females. These observations suggest a sex-specific strategy to colon cancer prevention.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20843489     DOI: 10.1016/j.ejca.2010.07.040

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  16 in total

Review 1.  Do recent epidemiologic observations impact who and how we should screen for CRC?

Authors:  Ethan Bortniker; Joseph C Anderson
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

Review 2.  Colorectal cancer survivorship: movement matters.

Authors:  Crystal S Denlinger; Paul F Engstrom
Journal:  Cancer Prev Res (Phila)       Date:  2011-04

3.  Receptivity and Preferences in Cancer Risk Reduction Lifestyle Programs: A Survey of Colorectal Cancer Family Members.

Authors:  Lisa A Howell; Tabetha A Brockman; Pamela S Sinicrope; Christi A Patten; Paul A Decker; Shawna L Ehlers; Noralane M Lindor; Sandra K Nigon; Gloria M Petersen
Journal:  J Behav Health       Date:  2013

4.  Exercise and Self-Reported Limitations in Patients with Inflammatory Bowel Disease.

Authors:  Ersilia M DeFilippis; Saniya Tabani; Ryan U Warren; Paul J Christos; Brian P Bosworth; Ellen J Scherl
Journal:  Dig Dis Sci       Date:  2015-08-09       Impact factor: 3.199

5.  Physical activity, mediating factors and risk of colon cancer: insights into adiposity and circulating biomarkers from the EPIC cohort.

Authors:  Krasimira Aleksandrova; Mazda Jenab; Michael Leitzmann; Bas Bueno-de-Mesquita; Rudolf Kaaks; Antonia Trichopoulou; Christina Bamia; Pagona Lagiou; Sabina Rinaldi; Heinz Freisling; Marion Carayol; Tobias Pischon; Dagmar Drogan; Elisabete Weiderpass; Paula Jakszyn; Kim Overvad; Christina C Dahm; Anne Tjønneland; Marie-Christine Bouton-Ruault; Tilman Kühn; Eleni Peppa; Elissavet Valanou; Carlo La Vecchia; Domenico Palli; Salvatore Panico; Carlotta Sacerdote; Claudia Agnoli; Rosario Tumino; Anne May; Jonna van Vulpen; Kristin Benjaminsen Borch; Sunday Oluwafemi Oyeyemi; J Ramón Quirós; Catalina Bonet; María-José Sánchez; Miren Dorronsoro; Carmen Navarro; Aurelio Barricarte; Bethany van Guelpen; Patrik Wennberg; Timothy J Key; Kay-Tee Khaw; Nicholas Wareham; Nada Assi; Heather A Ward; Dagfinn Aune; Elio Riboli; Heiner Boeing
Journal:  Int J Epidemiol       Date:  2017-12-01       Impact factor: 7.196

6.  Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP Cohort.

Authors:  Andrew G Renehan; Andrew Flood; Kenneth F Adams; Matthias Olden; Albert R Hollenbeck; Amanda J Cross; Michael F Leitzmann
Journal:  Am J Epidemiol       Date:  2012-11-27       Impact factor: 4.897

Review 7.  Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer.

Authors:  Prashant Kant; Mark A Hull
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-08       Impact factor: 46.802

Review 8.  Screening for colorectal cancer: possible improvements by risk assessment evaluation?

Authors:  Hans J Nielsen; Karen V Jakobsen; Ib J Christensen; Nils Brünner
Journal:  Scand J Gastroenterol       Date:  2011-08-19       Impact factor: 2.423

9.  9. Cancers attributable to inadequate physical exercise in the UK in 2010.

Authors:  D M Parkin
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

10.  Tackling the cancer burden: the economic impact of primary prevention policies.

Authors:  Jane Cheatley; Alexandra Aldea; Aliénor Lerouge; Marion Devaux; Sabine Vuik; Michele Cecchini
Journal:  Mol Oncol       Date:  2020-10-18       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.